483
Aero HealthcareAero Healthcare – FDA 483, May 6, 2022
Record Details
An FDA inspection of Aero Healthcare in Valley Cottage, NY, a monograph drug facility, revealed significant deficiencies in its quality control unit, facility security, and employee training. The firm failed to establish written quality agreements for OTC drug products manufactured by contract manufacturers and did not adequately review Certificates of Analysis. Additionally, access to labeling materials was not restricted, and GMP training for employees was insufficient.
View Company Profile
ID · 875f9549-4181-4fea-b3f7-34acab02523b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.